Finanzwire Finanzwire
Basculer en Français
10885 Companies
236936 Keywords
165832 Articles
127156 Press releases
Headlines Articles Press releases MustGrow Biologics Corp. Remove
  1. Home
  2. Companies
  3. MustGrow Biologics Corp.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 06/29/2026 at 11:05, 1 month 27 days ago

    MustGrow Biologics Corp: Strategic Shift and Financial Outlook

    Revenue Growth Strategic Transition MustGrow Biologics TerraSante Biologicals Market
  • PRESS RELEASE

    published on 06/29/2026 at 11:00, 1 month 27 days ago

    Original-Research: MustGrow Biologics Corp. (von GBC AG): BUY

    MustGrow Biologics Corp., a Canadian agricultural biologicals company, transitions to a more focused platform with commercial success of TerraSante product and strategic Bayer partnership
    Commercialization TerraSante MustGrow Biologics Corp Agricultural Biologicals Bayer Partnership
    Logo of MustGrow Biologics Corp.
  • BRIEF

    published on 02/19/2026 at 10:05, 6 months 7 days ago

    MustGrow Biologics Corp. Advances Sustainable Agriculture

    Sustainable Agriculture Market Expansion Regenerative Solutions MustGrow Partnership Biological Technology
  • PRESS RELEASE

    published on 02/19/2026 at 10:00, 6 months 7 days ago

    Original-Research: MustGrow Biologics Corp. (von GBC AG): Management interview

    MustGrow Biologics Corp. is at the forefront of commercializing regenerative agriculture with innovative biological technologies, providing eco-friendly alternatives to synthetic chemicals and fertilizers
    Innovation Regenerative Agriculture Eco-friendly Biological Technologies MustGrow Biologics Corp.
    Logo of MustGrow Biologics Corp.
Accesswire
  • Published on 08/27/2026 at 00:05, 59 minutes ago

    Kidoz Reports Record Q2 2026 Revenue, up 37%, as H1 Revenue Reaches US$6.28 Million (CAD$8.66 Million)

  • Published on 08/26/2026 at 23:00, 2 hours 4 minutes ago

    Datametrex Announces Transition to Semi-Annual Financial Reporting

  • Published on 08/26/2026 at 22:30, 2 hours 34 minutes ago

    AI/ML Innovations Inc. Closes First Tranche of Private Placement

  • Published on 08/26/2026 at 22:30, 2 hours 34 minutes ago

    Blueberries Medical Announces Closing of C$1.1 Million Non-Brokered Private Placement

  • Published on 08/26/2026 at 21:15, 3 hours 49 minutes ago

    Announces Private Placement of Convertible Promissory Notes

View all ACCESSWIRE
EQS Group
  • Published on 08/26/2026 at 23:05, 1 hour 59 minutes ago

    Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

  • Published on 08/26/2026 at 18:44, 6 hours 20 minutes ago

    AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results

  • Published on 08/26/2026 at 18:40, 6 hours 24 minutes ago

    MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM

  • Published on 08/26/2026 at 18:30, 6 hours 34 minutes ago

    Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China

  • Published on 08/26/2026 at 18:00, 7 hours 4 minutes ago

    MHM Corporate: reduces the nominal value of its shares to €0.011

View all EQS
Les Echos
  • Published on 08/26/2026 at 18:02, 7 hours 2 minutes ago

    Altareit: Altarea press release regarding the Primonial matter

  • Published on 08/26/2026 at 18:00, 7 hours 4 minutes ago

    Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)

  • Published on 08/26/2026 at 17:40, 7 hours 24 minutes ago

    First half 2026 results

  • Published on 08/25/2026 at 17:45, 1 day 7 hours ago

    CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 08/25/2026 at 17:45, 1 day 7 hours ago

    Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy